A case of chronic inflammatory demyelinating polyneuropathy following COVID-19 vaccine

Eiichi Katada; Takanari Toyoda; Gohei Yamada; Akira Morishima; Noriyuki Matsukawa

doi:10.1111/ncn3.12604

A case of chronic inflammatory demyelinating polyneuropathy following COVID-19 vaccine

Neurol Clin Neurosci. 2022 May 2:10.1111/ncn3.12604. doi: 10.1111/ncn3.12604. Online ahead of print.

Authors

Eiichi Katada¹, Takanari Toyoda¹, Gohei Yamada¹, Akira Morishima¹, Noriyuki Matsukawa²

Affiliations

¹ Department of Neurology Nagoya City University West Medical Center Nagoya Japan.
² Department of Neurology Nagoya City University Graduate School of Medical Sciences Nagoya Japan.

Abstract

We report a 44-year-old woman who presented with bilateral weakness of the hands and distal paresthesia of the arms on the next day of the second COVID-19 vaccine, and gradually progressed ascending weakness of the arms and legs, and sensory ataxia beyond 2 months. She was diagnosed as a chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID-19 vaccine on the basis of clinical and electrophysiological findings. This is a first case diagnosed as a CIDP following COVID-19 vaccine alone.

Keywords: COVID‐19 vaccine; Guillain–Barrẻ syndrome; chronic inflammatory demyelinating polyneuropathy.

Publication types

Case Reports